Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Skin problems are very common in people with end-stage kidney disease.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Keratin 79 marks a new group of cells that are key for creating and repairing the hair follicle's structure.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

SHBG may be a useful early indicator and treatment target for PCOS.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

DHT, a testosterone byproduct, causes male pattern baldness.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Some medications can cause acne, and stopping these drugs is the main treatment.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.